Keywords: evolutec, completes, recruitment, ph, ii, rev131, trial

Evolutec completes recruitment in Ph II rEV131 trial

Article | 20 November 2006

Print This

UK biopharmaceutical group Evolutec says it has completed recruitment in a Phase II proof-of-concept trial of its lead development compound, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in